Priya Uppuluri

Candida albicans SNO1 and SNZ1 expressed in stationary-phase planktonic yeast cells and base of biofilm.

Analysis of RNA species of various sizes from stationary-phase planktonic yeast cells of Candida albicans.

Defining Candida albicans stationary phase by cellular and DNA replication, gene expression and regulation.

Farnesol-mediated inhibition of Candida albicans yeast growth and rescue by a diacylglycerol analogue.

Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms.

A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing.

Hsp90 orchestrates temperature-dependent Candida albicans morphogenesis via Ras1-PKA signaling.

Design of a simple model of Candida albicans biofilms formed under conditions of flow: development, architecture, and drug resistance.

Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis.

Characteristics of Candida albicans biofilms grown in a synthetic urine medium.

Candida albicans biofilm formation and its clinical consequences.

Presence of extracellular DNA in the Candida albicans biofilm matrix and its contribution to biofilms.

Dispersion as an important step in the Candida albicans biofilm developmental cycle.

The transcriptional regulator Nrg1p controls Candida albicans biofilm formation and dispersion.

An easy and economical in vitro method for the formation of Candida albicans biofilms under continuous conditions of flow.

Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion.

Development of a high-throughput Candida albicans biofilm chip.

Hsp90 governs dispersion and drug resistance of fungal biofilms.